Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

339.50p
   
  • Change Today:
    -8.00p
  • 52 Week High: 1,582.00
  • 52 Week Low: 320.00
  • Currency: UK Pounds
  • Shares Issued: 3.60m
  • Volume: 7,700
  • Market Cap: £12.24m
  • RiskGrade: 340

Latest ShareCast News

Hemogenyx shares boosted by partner investment

By Benjamin Chiou

Date: Wednesday 02 Oct 2024

(Sharecast News) - Shares in Hemogenyx Pharmaceuticals jumped on Wednesday after the clinical-stage biopharmaceutical group announced another investment from Prevail Partners via a share subscription at a significant premium to the current market value.

Hermogenyx shares soar on new partnership with Prevail Partners

By Benjamin Chiou

Date: Monday 18 Sep 2023

(Sharecast News) - Shares in biopharma group Hemogenyx surged on Monday after the company received a $0.83m investment from Prevail Partners as it continues to work on its planned clinical trial for leukaemia treatment.

Hemogenyx signs another deal with unnamed global pharma company

By Josh White

Date: Wednesday 23 Oct 2019

(Sharecast News) - Biopharmaceutical group Hemogenyx Pharmaceuticals announced on Wednesday that its wholly-owned subsidiary Immugenyx has entered into a research agreement with a global pharmaceutical company.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 339.50p
Change Today -8.00p
% Change -2.30 %
52 Week High 1,582.00
52 Week Low 320.00
Volume 7,700
Shares Issued 3.60m
Market Cap £12.24m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.19% below the market average44.19% below the market average44.19% below the market average44.19% below the market average44.19% below the market average
62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average
Price Trend
85.9% below the market average85.9% below the market average85.9% below the market average85.9% below the market average85.9% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 10-Feb-2025

Time Volume / Share Price
15:47 2 @ 344.00p
16:20 3 @ 340.00p
15:47 2 @ 344.00p
15:30 400 @ 335.60p
14:11 92 @ 335.50p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page